EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways

Somayeh Piroozmand, Hamid Latifi-Navid, Zahra-Soheila Soheili, Saman Hosseinkhani, Shahram Samiei, Amir Barzegar Behrooz, Hamid Ahmadieh, Andrea Leonardi, Saeid Ghavami, Nader Sheibani

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.5.4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Somayeh Piroozmand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Aging, Angiogenesis Inhibitors, Retinal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Vision-threatening ocular diseases are impacted by aging-associated molecular changes, including mitochondrial dysfunction, cellular senescence, and chronic inflammation. Anti-VEGF therapies targeting VEGF-A/VEGFR2 signaling remain the frontline standard of care, but many patients exhibit suboptimal or nondurable responses, often due to compensatory and/or compromised antiangiogenic and anti-inflammatory pathways. We aimed to elucidate shared mechanisms underlying treatment failure and disease progression.

Methods

We applied an integrative systems biology framework that combined multiomics datasets, network-based machine learning, and disease-specific pathway mapping. A comprehensive literature review of conditions, including diabetic retinopathy, age-related macular degeneration, retinitis pigmentosa, glaucoma, and aging, identified 14 core genes consistently associated with angiogenesis, inflammation, and immune signaling. Multialgorithm centrality and enrichment analyses reconstructed disease-specific interaction networks, revealing consensus mechanistic axes. Integration of cell-type-specific single-cell RNA sequencing data from AMD-RPE clusters identified cluster-specific gene hubs and vertical signaling axes, leading to VEGF blockade failure.

Results

EGFR, HSP90AA1, SIRT1, and STAT3 emerged as central resistance hubs linking angiogenesis and inflammatory processes. Pathway enrichment analyses revealed 21 conserved core signaling cascades, grouped into six functional categories, with AGE-RAGE, PI3K-Akt, HIF-1, MAPK, and chemokine pathways playing central roles. A MiRGD-based peptide nanocomplex delivering htsFLT01 achieved efficient RPE transfection and controlled gene activation under basal conditions.

Conclusions

This systems-level framework clarifies mechanisms of VEGF blockade resistance and provides a rational basis for next-generation, combinatorial therapeutic strategies requiring validation in disease-relevant models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AAgingAngiogenesis InhibitorsRetinal DiseasesHumansSignal TransductionAnimalsSystems BiologyInflammation

Substanzen

Vascular Endothelial Growth Factor AAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • School of Biological Sciences, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.
  • Departments of Ophthalmology and Visual Sciences, and Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States.
  • Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
  • Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
  • Department of Human Anatomy and Cell Science, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada.

Zitieren

APA

Piroozmand, S., Latifi-Navid, H., Soheili, Z. S., Hosseinkhani, S., Samiei, S., Barzegar Behrooz, A., Ahmadieh, H., Leonardi, A., Ghavami, S., & Sheibani, N. (2026). Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.5.4

Vancouver

Piroozmand S, Latifi-Navid H, Soheili ZS, Hosseinkhani S, Samiei S, Barzegar Behrooz A, et al. Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.5.4

BibTeX
@article{Piroozmand2026,
  author = {Piroozmand, Somayeh and Latifi-Navid, Hamid and Soheili, Zahra-Soheila and Hosseinkhani, Saman and Samiei, Shahram and Barzegar Behrooz, Amir and Ahmadieh, Hamid and Leonardi, Andrea and Ghavami, Saeid and Sheibani, Nader},
  title = {Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.5.4}
}
Kostenlos starten →